Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value-Reference-Cited by-同舟云学术

Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value

Published:2016-04-04 Issue:12 Volume:36 Page:1867-1875
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

de Vries Elisabeth M. G.¹,Wang Junfeng²,Leeflang Mariska M. G.²,Boonstra Kirsten¹,Weersma Rinse K.³,Beuers Ulrich H.¹,Geskus Ronald B.²,Ponsioen Cyriel Y.¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Academic Medical Center; University of Amsterdam; Amsterdam the Netherlands

2. Department of Clinical Epidemiology; Biostatistics and Bioinformatics; Academic Medical Center; University of Amsterdam; Amsterdam the Netherlands

3. Department of Gastroenterology and Hepatology; University Medical Center Groningen; Groningen the Netherlands

Funder

Dr Falk Benelux

AbbVie

Tramedico

PSC Partners Seeking a Cure

VIDI

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13110/fullpdf

Reference23 articles.

1. Primary sclerosing cholangitis;Williamson;Dig Dis,2014

2. Primary sclerosing cholangitis;Hirschfield;Lancet,2013

3. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis;Boonstra;Hepatology,2013

4. The medical management of primary sclerosing cholangitis;Cullen;Semin Liver Dis,2008

5. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis;Karlsen;Aliment Pharmacol Ther,2014

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surrogate markers of bile duct disease progression in primary sclerosing cholangitis – A prospective study with repeated ERCP examinations;JHEP Reports;2024-10

2. The new definition of dominant stricture in primary sclerosing cholangitis: Prevalence and clinical significance;Liver International;2024-06-06

3. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape;Expert Opinion on Investigational Drugs;2024-03-18

4. Is there any association between celiac disease, myelodysplastic symdrome and primary sclerosing cholangitis?: A rare case report;JGH Open;2024-03

5. Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis;Hepatology Communications;2024-02-14